RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sophia Genetics Stock

Sophia Genetics ROCE 2025

Sophia Genetics ROCE

-0.69

Ticker

SOPH

ISIN

CH1125843347

WKN

A3CVT8

In 2025, Sophia Genetics's return on capital employed (ROCE) was -0.69, a 39.63% increase from the -0.49 ROCE in the previous year.

Sophia Genetics Aktienanalyse

What does Sophia Genetics do?

Sophia Genetics SA is a Swiss company that was founded in 2011. The idea behind it was to improve genome sequencing and data analysis in order to make faster and more precise medical diagnoses. Sophia Genetics has since become a leading provider of artificial intelligence and data analysis in the medical field. The business model of Sophia Genetics is based on providing doctors and medical facilities with corresponding data analysis tools and platforms. Sophia Genetics' algorithms help to identify genetic anomalies and develop personalized therapies. This personalized medicine aims to improve healthcare. Sophia Genetics is divided into various sectors. The core sectors include oncology, pediatrics, cardiology, and neurology. In these specialized fields, Sophia Genetics' platforms and tools are used to optimize genome sequencing and data analysis, thus enabling faster and more precise diagnoses. The company offers a variety of products that help doctors and medical facilities create successful diagnoses and therapies. Sophia Genetics' flagship product is the Sophia Artificial Intelligence (AI) platform. This platform is used by doctors, clinics, and research institutions to analyze complex data and identify the genetic causes of diseases. The Sophia AI platform provides fast, precise, and secure genome sequencing and data analysis. Sophia Genetics also offers the Sophia DDM system. The DDM system is a cloud-based data exchange system that provides doctors and medical facilities with a secure way to exchange confidential medical data. The system also allows for the collection and analysis of information about diseases and disease progression in the population, in order to enable better healthcare. Another important product of Sophia Genetics is the Sophia Hereditary Cancer Solution. This product helps in the early detection of hereditary cancer. The Sophia Hereditary Cancer Solution provides fast and precise genetic diagnostics to identify family members at increased risk of cancer and take appropriate measures. Another product of Sophia Genetics is Sophia Radiomics. This software uses artificial intelligence and machine learning to detect and characterize diseases based on X-ray and CT scans. By analyzing large amounts of data, the Sophia Radiomics software can assist doctors in making more precise diagnoses and better treatment decisions. Sophia Genetics relies on close collaboration with medical facilities and research institutions worldwide. The company now has customers in over 60 countries and is a partner to more than 1,000 hospitals worldwide. Sophia Genetics' platforms and tools have already helped many people to be diagnosed and treated faster and more accurately. Overall, Sophia Genetics is an innovative company that has revolutionized medical diagnostics. With its advanced platforms and tools, the company provides doctors and medical facilities with an excellent opportunity to develop personalized therapies and enable better healthcare. Please write only the answer in the output. Sophia Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Sophia Genetics's Return on Capital Employed (ROCE)

Sophia Genetics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Sophia Genetics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Sophia Genetics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Sophia Genetics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Sophia Genetics stock

What is the ROCE (Return on Capital Employed) of Sophia Genetics this year?

The ROCE of Sophia Genetics is -0.69 undefined this year.

How has the ROCE (Return on Capital Employed) of Sophia Genetics developed compared to the previous year?

The ROCE of Sophia Genetics has increased by 39.63% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Sophia Genetics?

A high Return on Capital Employed (ROCE) indicates that Sophia Genetics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Sophia Genetics?

A low ROCE (Return on Capital Employed) can indicate that Sophia Genetics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Sophia Genetics impact the company?

An increase in the ROCE of Sophia Genetics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Sophia Genetics affect the company?

A decrease in ROCE of Sophia Genetics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Sophia Genetics?

Some factors that can affect Sophia Genetics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Sophia Genetics so important for investors?

The ROCE of Sophia Genetics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Sophia Genetics take to improve the ROCE?

To improve the ROCE, Sophia Genetics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Sophia Genetics pay?

Over the past 12 months, Sophia Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sophia Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Sophia Genetics?

The current dividend yield of Sophia Genetics is .

When does Sophia Genetics pay dividends?

Sophia Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sophia Genetics?

Sophia Genetics paid dividends every year for the past 0 years.

What is the dividend of Sophia Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sophia Genetics located?

Sophia Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sophia Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sophia Genetics from 6/24/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/24/2025.

When did Sophia Genetics pay the last dividend?

The last dividend was paid out on 6/24/2025.

What was the dividend of Sophia Genetics in the year 2024?

In the year 2024, Sophia Genetics distributed 0 USD as dividends.

In which currency does Sophia Genetics pay out the dividend?

The dividends of Sophia Genetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sophia Genetics

Our stock analysis for Sophia Genetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sophia Genetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.